Clinical Research

EARLY TAVR update: New data highlight continued benefits of treating asymptomatic aortic stenosis
Philippe Généreux, MD, presented updated findings from one of cardiology's most closely watched trials at New York Valves 2026.
Shockwave Medical announces new studies evaluating carotid IVL platform
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
TAVR with Edwards Lifesciences valve for severe AR linked to ‘encouraging’ data
All patients presented with severe aortic regurgitation. The study's findings were presented at New York Valves 2026 and published in JSCAI.
Pigeons excel at spotting abnormalities on CT scans
Researchers believe pigeons' perceptual processes could be used to develop artificial intelligence applications in radiology.
Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis
TAVR was associated with early benefits for women. After five years, however, outcomes were comparable across the board.

Brain anatomy differs between people with opposing political ideologies

New research indicates that conservatives have larger amygdalas than their more progressive-leaning counterparts.

SAVR associated with several long-term benefits for patients with asymptomatic severe AS

The current evidence suggests early surgery is a better treatment option for asymptomatic severe AS than conservative care, researchers explained.

Harlan Krumholz, MD, SM, editor-in-chief of the Journal of the American College of Cardiology (JACC), and a cardiologist and the Harold H. Hines, Jr. Professor of Medicine at the Yale school Medicine, explains some of the key technology advances he is watching across cardiology.

JACC editor excited by progress during a 'very important moment' for cardiology

Harlan Krumholz, MD, editor-in-chief of the Journal of the American College of Cardiology, explains some of the key technology and treatment trends he has his eyes on.

Nemours Children's Hospital pediatric cardiologists explain lessons learned about cardiac involvement and long-term issues from multisystem inflammatory syndrome in children (MIS-C), a rare but serious disease caused by exposure to the COVID-19 virus. #MIS-C #COVID #coronavirus #SARSCoV2

A key update on how COVID-19 caused dangerous MIS-C inflammation in children

The rise of MIS-C during the COVID-19 pandemic alarmed physicians and patients alike, and the exact cause was unclear. Now, new NIH-funded research appears to provide some answers.

Novel radiotracer could improve the diagnosis of interstitial lung disease

Researchers are hopeful that uptake of the molecular SPECT imaging agent will help providers more ably monitor disease progression.

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).

TRILUMINATE update: TEER with Abbott’s TriClip device still safe, effective after 3 years

Treatment with TriClip has been consistently associated with minimal adverse events and significant improvements in quality of life. This latest update represents data from nearly 100 patients three years after implantation.

Polaris Dawn astronauts will undergo brain MRIs upon landing

The scans will be conducted earlier than any other post-flight imaging of astronauts on record.

CT scans highlight impact of semaglutide on body composition

Body composition metrics derived from CT scans provide greater insight into how losing weight affects the body from a cardiometabolic perspective.

Clinical Research

EARLY TAVR update: New data highlight continued benefits of treating asymptomatic aortic stenosis

Shockwave Medical announces new studies evaluating carotid IVL platform

TAVR with Edwards Lifesciences valve for severe AR linked to ‘encouraging’ data

Pigeons excel at spotting abnormalities on CT scans

Sex-specific outcomes after TAVR and SAVR: Key takeaways from a new meta-analysis